29 Article(s)Download |
||||||
PMID | Title | Pub. Year | #Total Relationships |
|||
1 | 34504783 | RanBP3 Regulates Proliferation, Apoptosis and Chemosensitivity of Chronic Myeloid Leukemia Cells via Mediating SMAD2/3 and ERK1/2 Nuclear Transport. | 2021 | 1 | ||
2 | 30866043 | Neferine in the Lotus Plumule Potentiates the Antitumor Effect of Imatinib in Primary Chronic Myeloid Leukemia Cells In Vitro. | 2019 Apr | 1 | ||
3 | 30504658 | [MET/ERK and MET/JNK Pathway Activation Is Involved in BCR-ABL Inhibitor-resistance in Chronic Myeloid Leukemia]. | 2018 | 1 | ||
4 | 28103766 | Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia. | 2017 May 1 | 1 | ||
5 | 28418880 | Contributions of MET activation to BCR-ABL1 tyrosine kinase inhibitor resistance in chronic myeloid leukemia cells. | 2017 Jun 13 | 1 | ||
6 | 28927158 | Regulation of HtrA2 on WT1 gene expression under imatinib stimulation and its effects on the cell biology of K562 cells. | 2017 Sep | 2 | ||
7 | 26919095 | Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies. | 2016 Apr 5 | 3 | ||
8 | 25182956 | KIT and BRAF heterogeneous mutations in gastrointestinal stromal tumors after secondary imatinib resistance. | 2015 Oct | 2 | ||
9 | 23146907 | Ableson kinases negatively regulate invadopodia function and invasion in head and neck squamous cell carcinoma by inhibiting an HB-EGF autocrine loop. | 2013 Oct | 1 | ||
10 | 22173128 | C-Kit controls IL-1β-induced effector functions in HMC-cells. | 2012 Jan 30 | 1 | ||
11 | 22327338 | c-ABL modulates MAP kinases activation downstream of VEGFR-2 signaling by direct phosphorylation of the adaptor proteins GRB2 and NCK1. | 2012 Jun | 1 | ||
12 | 22798315 | A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents. | 2012 Oct 1 | 1 | ||
13 | 22875343 | Raf/MEK/ERK signaling inhibition enhances the ability of dequalinium to induce apoptosis in the human leukemic cell line K562. | 2012 Aug | 1 | ||
14 | 20596710 | Imatinib mesylate enhances the malignant behavior of human breast carcinoma cells. | 2011 Apr | 1 | ||
15 | 21152856 | Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells. | 2011 Feb | 1 | ||
16 | 21299849 | BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance. | 2011 Feb 7 | 2 | ||
17 | 21727212 | Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2. | 2011 Jul | 1 | ||
18 | 22096574 | The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines. | 2011 | 1 | ||
19 | 19843070 | Contribution of BCR-ABL-independent activation of ERK1/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells. | 2010 Jan | 7 | ||
20 | 20811709 | Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells. | 2010 Oct | 1 | ||
21 | 19225164 | Preadipocyte apoptosis is prevented by macrophage-conditioned medium in a PDGF-dependent manner. | 2009 Apr | 1 | ||
22 | 18626307 | Changes in pERK1/2 and pAKT expression in melanoma lesions after imatinib treatment. | 2008 Aug | 1 | ||
23 | 17495975 | The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-alpha-expressing cells through caspase-3-mediated cleavage of Mcl-1. | 2007 Jul | 1 | ||
24 | 17581316 | Induction of urokinase-type plasminogen activator, interleukin-8 and early growth response-1 by STI571 through activating mitogen activated protein kinase in human small cell lung cancer cells. | 2007 Jul | 2 | ||
25 | 15094364 | Role of E2F and ERK1/2 in STI571-mediated smooth muscle cell growth arrest and cyclin A transcriptional repression. | 2004 May 14 | 3 | ||
26 | 15100154 | Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo. | 2004 Aug 15 | 1 | ||
27 | 12850478 | Involvement of Akt kinase in the action of STI571 on chronic myelogenous leukemia cells. | 2003 Jul-Aug | 1 | ||
28 | 12939459 | Response markers and the molecular mechanisms of action of Gleevec in gastrointestinal stromal tumors. | 2003 Aug | 1 | ||
29 | 14555991 | Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. | 2003 Oct 2 | 1 |